BBIO Operating Expenses

Bridgebio Pharma Inc · Operating Expenses

BBIO logo

BBIO Operating Expenses

Latest reported$1.21B
BBIO TTM Operating Expenses ($183.66M → $1.21B)
High-resolution chart · PNG

BBIO operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bridgebio Pharma Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
1,209,091,000
1,114,572,000
1,042,892,000
948,717,000
883,265,000
819,184,000
810,997,000
759,735,000
727,036,000
697,068,000
614,227,000
566,119,000
533,649,000
539,730,000
586,416,000
632,910,000
654,584,000
649,292,000
643,234,000
593,896,000
571,573,000
548,210,000
482,731,000
447,577,000
398,284,000
343,035,000
304,300,000
277,426,000
240,109,000
205,574,000
183,660,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.